Dose-dependent osteoinductive effects of bFGF in rabbits

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Research

Background:

• Growth factors promote tissue regeneration in bone healing when applied to biomaterials.
• Basic fibroblast growth factor (bFGF) possesses osteoinductive and neoangiogenic properties.

Purpose of the Study:

• To evaluate the efficacy of bFGF-coated hydroxylapatite implants in promoting bone regeneration.
• To compare different dosages of bFGF (10 microg and 100 microg) against uncoated controls.

Main Methods:

• Utilized the rabbit patellar groove model for bone defect evaluation.
• Assessed bone growth and labeling in groups with bFGF-coated and uncoated hydroxylapatite implants.
• Compared outcomes between 10 microg and 100 microg bFGF dosage groups.

Main Results:

• No significant difference in bone growth was observed between bFGF-coated and control implants after 35 days.
• The 100 microg group exhibited stronger bone labeling (days 19-25) compared to the 10 microg groups.
• The 10 microg group showed earlier bone labeling, potentially indicating an inhibitory effect at higher doses or osteoclast induction.

Conclusions:

• bFGF coating on hydroxylapatite implants did not enhance bone regeneration in this model.
• Higher bFGF concentrations may have an inhibitory effect on bone healing.
• The study suggests a possible systemic effect of transient growth factor coatings.